China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
士卓曼（北京）医疗器械贸易有限公司
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (北京市市场监督管理局北京市市场监督管理局 · 市场监管总局发布士卓曼（北京）医疗器械贸易有限公司垄断协议案行政处罚决定书), from 30 December 2022.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 士卓曼（北京）医疗器械贸易有限公司
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 北京市市场监督管理局北京市市场监督管理局 · 市场监管总局发布士卓曼（北京）医疗器械贸易有限公司垄断协议案行政处罚决定书
- From
- 30 December 2022
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_ab9f13fe772d4980ba0e39eadfbb83c3.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)